Synthetic Blood International Inc
Selected Abstract
Synthetic Blood International Inc. releases clinical trial schedule for three products.
SAN DIEGOBUSINESS WIREJune 9, 1995--Synthetic Blood International Inc. (SYBD) Friday released a report prepared by San Diego Clinical Research Associates (SDCRA) that outlines the clinical trial schedule for its research and development through 1996. SYBD is developing three biomedical products: an ... June 9, 1995; Business Wire
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
Synthetic Blood International, Inc. (OTCBB:SYBD) just released some important news.
2.
Synthetic Blood International, Inc. to Open New Research Office at Virginia BioTechnology Research Park.
3.
Synthetic Blood International, Inc. Announces Passing of Interim CEO Robert Larsen.
4.
Synthetic Blood International, Inc. Announces New Leadership Roles to Continue Product Development Strategy.
5.
Synthetic Blood International, Inc. Shareholders Approve Name Change and Reincorporation.
6.
Synthetic Blood International, Inc. Announces Plans to File Protocol for Phase II-b Oxycyte(R) Clinical Trial.
7.
Synthetic Blood International, Inc. Announces Filing of Protocol for Phase II-b Oxycyte Clinical Trial.
8.
Synthetic Blood International, Inc. to Seek Shareholder Approval for Name Change.
9.
Synthetic Blood International, Inc. Acquires Exclusive License to Use New VCU Intellectual Property.
10.
rd of Directors.
|
